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Abstract
In Lao PDR, where more than 8% of the population are chronic carriers of HBsAg, multiple genotypes and subgenotypes co-
circulate and are prone to generate recombinant viruses. Phylogenetic analyses of multiple clones per donor revealed mixed
infections of subgenotypes B1, B2, B4, C1, C5, I1 and I2 in almost 6% of HBsAg positive rejected blood donors.
Recombination analyses and distance calculations furthermore showed that about 65% (17/26) of the mixed infected
donors showed recombinations in the S-gene alone, involving the predominant genotypes B and C. These results suggest
that, at least in Laos, hepatitis B virus (HBV) mixed infections lead to frequent recombinations. In many donors with
recombinant strains, the recombinant fragment and a non-recombinant strain of the same genotype co-existed (127/185
analysed recombinant fragments). For a large proportion of these (60/127), the most closely related known virus was found,
although not always exclusively, in the same donor. Recombinant virus strains are largely distinct. This is reflected in an
unexpected diversity in recombination breakpoints and the relatively rare recombinations with identical recombination
patterns of the same genotypes in different donors. Recent recombination events would explain the limited spread of each
of the recombinants. Using a published mutation rate of 4.2610
25 mutations per site and year, the observed minimum
genetic distances of 0–0.60% between parent strain and recombinant fragment would correspond to 0–71 years of
evolution from a most recent common ancestor (MRCA). Thus several lines of evidence are suggestive of recent
independent recombination events, a proportion of these even occurring within the same donors. In conclusion, our
analyses revealed a high variability of mixed infections as a very probable breeding ground of multiple variable
recombination events in Laos that so far have not led to new dominant strains.
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Introduction
Hepatitis B virus (HBV), a major global public health burden, is
classified into 8 recognised genotypes A-H [1,2] and a tentative
genotype I found in Laos [3], Vietnam [4,5,6] and also in
Northwestern China [7] and India [8]. Recently a tenth genotype
J has been proposed in a Japanese patient [9]. With the exception
of genotypes E, G and H, HBV genotypes are divided into
subgenotypes with more or less distinct geographic distributions
[1,2,10,11].
In Asia, genotypes B and C largely dominate and are divided
into a number of subgenotypes. While B1 (formerly Bj) is mainly
found in Japan and represents the non-recombined B subgenotype
[12], subgenotypes B2 to B4 (formerly Ba) largely originate from
mainland Asia and are recombinants with genotype C. B2 is
mainly found in China and Southeast Asia, B3 mainly in
Indonesia and B4 in Laos, Vietnam, Cambodia and China
[2,3,13]. The subgenotypes B5 and B6 have been isolated in the
Philippines and from the Canadian Inuit populations, respectively,
and subgenotypes B7, B8 and B9 have been proposed in Indonesia
[14,15,16]. Also genotype C strains group into several subgeno-
types. According to the nomenclature from Huy et al. [11],
subgenotype C1 represents predominantly strains from mainland
Asia (Laos, Vietnam, Thailand and Myanmar), while C2 is
prevalent in Japan, Hong Kong, China and Korea [2,10,11,17].
Subgenotype C3 consists of strains from Oceania, C4 of strains
exclusively from Australia and subgenotype C5 strains have been
reported from the Philippines, Indonesia, Vietnam and Laos
[3,4,18,19]. Additionally, subgenotypes C6 to C10 have been
proposed recently for strains from the Philippines and Indonesia
[3,19,20].
In highly endemic countries, particularly in Asia where different
HBV genotypes and subgenotypes co-circulate, mixed infections
[21,22,23,24] and recombinations have been described
[3,25,26,27,28,29,30,31]. For instance, in China almost 50% of
infections are mixed [22] and mixed infections have also been
reported from Thailand [32].
Recombination events do not seem to be negligible artefacts of
HBV co-infections, as recombinant strains have become the
dominant variant in certain regions. For example subgenotype Ba,
a B/C recombinant, prevails in major parts of mainland Asia, and
a recombinant between genotypes C and D has become the
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recombinant variant that circulates in Laos and Vietnam has been
proposed as a new HBV genotype I [3,4,5,6]. Nevertheless, only
few systematic studies of HBV recombinants have been published
from regions with intensive co-circulation of several HBV
subgenotypes [3,12,29].
In Laos, with 8.7% of chronic carriers [33], multiple HBV sub-/
genotypes co-circulate [3] and were shown to belong to genotype
C (55.4%), with subgenotypes C1 (93.1% of genotype C strains),
C5 (6.4%) and C3 (0.5%), genotype B (42.2%), with subgenotypes
B4 (78.5% of genotype B strains), B2 (11%), B5 (9.8%) and B3
(0.6%) and the suggested genotype I (2.4%), with subgenotypes I1
and I2 [3]. As a result of the high prevalence of chronic HBV
carriers and the co-circulation of multiple genotypes and
subgenotypes, Laos is prone to generate recombinant viruses.
Here, we systematically analysed mixed infections and recombi-
nations in 42 HBV strains from HBsAg positive first time blood
donors. Our study revealed an unusual cauldron of mixed
infections as a breeding ground of multiple and highly variable
recombination events that so far have not led to new dominant
strains.
Methods
Ethics Statement
Blood samples were collected by the National Blood Transfu-
sion Centre, Lao Red Cross, Lao PDR from voluntary blood
donors. All blood donors gave written consent to test their blood
for Hepatitis B and C virus, HIV and syphilis and to use the
leftover of the samples positive for HBsAg for the present study.
The study has been approved by the competent Ethical
Committee of the Faculty of Medical Sciences, National
University of Laos and was conducted according to national and
international guidelines.
Specimens
DNA was extracted using the QIAGEN DNA Blood Mini Kit
(QIAGEN, Venlo, The Netherlands), from sera of 40 HBsAg
positive, but otherwise healthy, rejected first time blood donors
from Vientiane City and Central provinces of Laos (collected in
2004/2005) and of 2 donors from the North of Laos (2006).
Amplification and cloning
The HBV S gene was amplified in a semi-nested format as
described previously [34], using forward primer P2f (59-
CCTGCTGGTGGCTCCAGTTC-39) and reverse primer 979
(59-CAAAAGACCCACAATTCTTTGACATACTTTCCAAT-
39). PCR products were cloned, using the TOPO TA cloning kit
(Invitrogen, Leek, The Netherlands). Bacteria were plated onto
Luria-Bertani-Broth agar plates, in the presence of kanamycin
[30 mg/ml] and X-Gal. White colonies were picked and inserts
were amplified by colony-PCR using M13fw (59-GTAAAAC-
GACGGCCAG-39) and M13rv (59-CAGGAAACAGCTAT-
GAC-39) primers.
Sequencing and phylogenetic analysis
The M13 PCR products, with 10 to 31 clones per donor, were
purified and sequenced as described before [34] with above
primers. Phylogenetic analysis and distance calculations were
performed, using the MEGA v.4 software [35] with the neighbour-
joining method of the Kimura 2-parameter model and a c value of
0.6, with 1,000 bootstrap replicates. Sequences were submitted to
EMBL/GenBank/DDBJ under accession numbers: HE652134 -
HE652863.
Recombination analysis
Bootscan analyses were performed using SimPlot v.3.5.1 [36]
with a window size of 200 bp and a step size of 20 bp.
Recombination breakpoints were confirmed by comparing each
recombinant sequence with consensus sequences with a threshold
of 50% for inclusion in the consensus nucleotide sequence
(consensus-50) [25] of subgenotypes B1-B8, C1-C7 and I1, I2.
Of these, the subgenotype B6 consensus-50 harboured one
ambiguous nucleotide. Additionally, consensus-50 sequences of
genotypes B, C and I were included in the analysis, reconstructed
from the associated consensus-50 sequences of the above
subgenotypes to exclude a bias of the differently sized sequence
sets available. The individual fragments of the potential recom-
binant strains were confirmed by phylogenetic analyses.
Results
Genotypes and subgenotypes
In 9157 blood donors in Vientiane city and central provinces
from 2004 and 2005 the HBsAg prevalence was 8.8%. Of the 498
available samples of HBsAg positive blood donors, 453 were found
to be PCR positive, 446 of them at least for the S gene. Sequence
analyses of these donors revealed at least 5 ambiguous nucleotides
within the amplified S gene of 40 donors, indicative of infections
with several HBV variants. In addition, 2 donors from Luang
Prabang in the North of Laos were suspected to be mixed infected
and included in the analyses. The S gene PCR products from these
42 donors were further characterized by extensive cloning.
Phylogenetic analyses revealed that among the 730 clones of
these 42 donors, 16 donors had only clones of the same
subgenotype (Table 1). Of these 16 non-mixed/non-recombined
samples, strains from 12 donors belonged to subgenotypes B4 and
one each to C1, and I1. Genotype B strains of the remaining 2
donors could not further be subgenotyped (Table 2; nomenclature
according to Huy et al. [11]). The Asian recombinants, assigned to
subgenotype B2-B4 (former Ba), and the proposed genotype I are
not considered recombinants for the purpose of this study.
Mixed, non recombinant. The other 26 donors, or 5.8% of
the 446 donors that were PCR positive for the S gene, were mixed
infected with different variants. For 9 of these donors (14 to 30
clones) all clones were clearly assigned to a sub-/genotype, whereas
the remaining 17 donors (3.8% of the 446 S gene PCR positive
donors) had at least one (and up to 27 clones of the 10 to 31 clones
generated) with signs of a recombination within the S fragment
(Table 1). In addition, recombination events were detected in 2
strains from Laos already published on NCBI (accession
nos. FJ023979, FJ023832) which were included in the analyses.
Table 1. Number of donors suspected to be mixed infected
with at least 2 sub-/genotypes of HBV, Lao PDR.
Samples No. donors
Detection-PCR positive 453
S-gene PCR positive 446
Total analyzed/suspected mixed infection 42
Non-mixed, non-recombinant 16
Total mixed 26
Mixed, non-recombinant 9
Mixed, recombinant 17
doi:10.1371/journal.pone.0030245.t001
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least one clone of 7 of the donors was assigned to genotype C1,
while the second sub-/genotype varied and belonged to sub-
genotypes B4 (n=1 donor), C5 (n=1 donor), I2 (n=1 donor), and
non-subgenotypable genotype B clones (n=2 donors), while for
one donor each B1 and B4, or C5 and B4 was found in addition to
C1. For two donors no clone was assigned to genotype C and
clones were attributed to genotypes B2 and B4 as well as B4 and
non-subgenotypable B clones (Table 2).
Mixed, recombinant. In the other 17 donors with mixed-
infections at least one clone showed signs of recombinations, and
at least one clone showed no such evidence. 16 of these donors had
non-recombined clones, that were assigned to genotype C, 15 to
genotype B and 1 to genotype I, with subgenotypes C1 (n=16),
C5 (n=1), B4 (n=14) and I1 (n=1) (Table 2). Strains of one
donor were attributed to genotype C, but clustered separately from
all HBV/C subgenotypes. Additionally, genotype B clones from 3
donors could not be subgenotyped, as the reference strains for
genotype B subgenotypes B3, B5, B7 and B8 clustered interspersed
with each other and the investigated strains (Figure 1).
Deletions and insertions. The S gene of the 730 clones was
681nt long, except for 7 clones, consisting of genotypes C1, B4 and
B which contained single nt deletions (3 clones in donors with
mixed infected, non-recombinant clones and 4 clones in donors
with recombinant strains). For another 6 clones, consisting of
genotypes B4 and B, the S gene sequence could not be fully
recovered.
Control experiments
Considering the large proportion of recombinant strains
detected in this study, we performed extensive tests to exclude
that there may be recombinants due to PCR or other artefacts.
Therefore, M13 products of cloned, characterized HBV/B and
HBV/C strains were mixed in various ratios (1:25, 1:5, 1:1, 5:1
and 25:1) and concentrations (1 ng and 100 ng total DNA) and
amplified using different elongation times (1 min elongation as in
the study protocol and a reduced elongation time of 20 sec). PCR
products were cloned by TOPO TA, using the above standard
protocol, amplified by M13 PCR and sequenced. In the 1 min
elongation PCR only rare recombinants (,2%, 2/107 clones)
were found (Table 3). Only when the elongation time was reduced
to 20 sec the rate of recombinations increased to an overall 16%
(18/111 clones). At 1 ng final concentration and 20 sec elongation
6.4% of clones showed recombinations. This increased to 39.4%
when using 100 ng template DNA and the short elongation time
(Table 3). Thus recombinant artefacts seem to depend on high
template concentrations and short elongation times.
After PCR amplification of our clinical samples the highest final
concentration of PCR product before cloning was 154 ng/ul,
corresponding to a template starting concentration considerably
lower than the nanomolar concentrations of DNA analysed in the
above control experiments. Although we cannot exclude that some
recombinants may have developed only when the concentration of
template increased during the later amplification cycles, these
recombinants would be relatively rare and unlikely to be picked up
during the cloning. This confirms that under our experimental
conditions only very few recombinants (of the observed 9.9% of
recombinant clones) would be the result of PCR artefacts. We also
excluded that recombinations may have occurred during cloning.
Thus, the observed high prevalence of recombinant clones in
65.4% of mixed infected donors is essentially free of PCR
dependent or other artefacts.
Distance calculations of non-mixed, non-recombined
samples
Distance calculations were performed in clearly subgenotypable
clones of individual donors, with at least 5 clones of the respective
subgenotype, including only clones for which the full S-gene could
be recovered. These clones formed quasispecies within individual
donors and revealed relatively low mean intra-group diversities for
subgenotypes B2 (0.47%; n=1 donor) and B4 (0.08–0.47%;
n=24), subgenotypes C1 (0.05–0.82%; n=11) and C5 (0.04%;
n=1), as well as subgenotypes I1 (0.34%; n=1) and I2 (0.25%;
n=1).
Amino acid analysis of clearly genotypable strains
The comparison of 651 clearly genotypable strains (excluding
the 7 clones with nucleotide insertions that were not considered for
analyses on the amino acid level) with consensus-50 sequences of
genotypes B, C and I as well as their subgenotypes revealed
multiple and variable amino acid (AA) changes over the S protein.
HBV/B clones. In 469 HBV/B clones, including the 6 clones
of which the S gene sequence could not be fully recovered, AA
substitutions occurred in 120 of 227 AA positions. In 7 of these
positions substitution occurred in .5 clones: T27A/I/V (n=7
clones of d=5 donors), S61L/A (n=6, d=6), P62L (n=6, d=5),
C76Y/R (n=8, d=6), P120S/T/L (n=20, d=14), M133I
(n=31, d=2), T140I (n=8, d=6). Furthermore, a total of 6
internal stop codons (*) were detected.
HBV/C clones. In 154 genotype C clones we found AA
substitutions in 56/227 positions, with 2 occurring in .5 clones:
I92T (n=11, d=1), T118M/P (n=51, d=15). In the genotype C
strains, a total of 4 internal stop codons were detected.
HBV/I clones. In the 28 genotype I clones, 19/227 AA
positions were found to harbour substitutions. Due to a lower
Table 2. Sub-/genotypes in HBV mixed infections in Lao PDR.
Category Sub-/genotype(s) No. donors
Donors suspected/analyzed n/a* 42
Non-mixed, non-recombinant donors
(n=16)
B2
B4 12
C1 1
I1 1
Clones in mixed, non-recombinant
donors (n=9)
B4, B 1
B4, B2 1
B4, C1 1
C1, B 2
C1, C5 1
C1, I2 1
B1, B4, C1 1
B4, C1, C5 1
Clones in mixed, recombinant donors
(n=17)
B1
B4, B, C1 2
C1, C5, B4 1
B4, C1 11
C1, C 1
C1, I1 1
*n/a: not applicable.
doi:10.1371/journal.pone.0030245.t002
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substitutions per site were further characterized. The investigated
strains were found to harbour P111L/Q (n=2, d=2), I226N
(n=12, d=1). In the genotype I strains, a total of 2 internal stop
codons were detected.
Vaccine or treatment associated mutations. Despite the
frequent amino acid substitutions only rare mutants had been
described previously as vaccine or treatment associated mutations
[37,38,39], including P120T (n=5, d=4), G145R (n=1), W172*
(n=2, d=2), W182* (n=2, d=2), L192F (n=1), W196* (n=1),
M198I (n=18, d=2) and W199* (n=1).
HBsAg subtypes. All 4 major HBsAg subtypes, that have
been described previously in genotype B and C strains from Asia
[2], were found among the analysed clones. In the 469 analysed
genotype B strains HBsAg subtype ayw1 predominated (n=444
clones, d=35 donors), while 18 clones (d=3) were attributed to
adw2 and one (d=1) to ayw2. Three clones (d=3) harboured
127S and were attributed to ayw. For three additional clones no
HBsAg subtyping could be performed, as two clones harboured
AA substitutions 122G or 160E and for one clone the HBsAg
sequence could not be fully recovered.
The 154 genotype C strains belonged primarily to subtype adr
(n=122, d=25), but also to adw2 (n=30, d=4), ayr (n=1, d=1)
and ayw1 (n=1, d=1).
In the 28 genotype I strains on the other hand both adw2
(n=16, d=2) and ayw1 (n=12, d=1) prevailed.
Description of recombinant clones
A total of 72 recombinant clones were detected in the 42
analysed donors, from which 730 clones were generated. In 17
donors at least one recombinant clone was detected. All of the 72
recombinant clones exhibited one or two recombination site(s)
within the S gene and revealed recombinations between genotypes
B and C (Figure 2). Of the 185 genotypable fragments 72 were
assigned to genotype B and 113 to genotype C.
In none of the analysed recombinant strains the recombination
breakpoint could be exactly defined because homologous stretches
of at least 17 nt length separated the recombined fragments
(Figure 2). Interestingly, recombinations occurred all over the S-
gene: nt 1–170 with 10 recombinant sites, nt 171–510 with 58
recombinant sites and nt 511–681 with 45 recombinant sites
(Figure 2).
For each of the individual 185 fragments of the 72 cloned
recombinants the most similar strains were identified by
phylogenetic analyses and pairwise comparison with a carefully
selected dataset that was composed of all available, clearly
subgenotypable full-length genome strains from NCBI (accessed
08/2011) and all non-recombinant strains from this study.
Based on the simplest evolutionary model with a mutation rate
of 4.2610
25 mutations per site and year [40], the time of
evolution from a hypothetical most recent common ancestor
(tMRCA) was calculated. For 127 of the 185 fragments a non-
recombinant strain of the same genotype was detected in the same
donor. Two of the 127 fragments were most closely related
(Kimura-2-parameter, pair wise genetic distances) to strains of the
same donor (0% and 0.5%), with minimum genetic distances
corresponding to 0 and 60 years of evolution from a hypothetical
MRCA, while 58 fragments (of the 127) were genetically
equidistant to clones found within the same donor and to strains
from other origins (0–0.7%, 0–83 years to a MRCA). In 13 of the
latter 2 and 58 fragments, the tMRCA was lower than or equal to
the age of the donor. The remaining 67 of the above 127
fragments were most closely related to strains from another source
(0–7.6%, 0–905 years to a MRCA).
58 of the above 185 fragments of recombinant strains, however,
originated from donors that were not coinfected with a strain of the
genotype found in the recombinant fragments. Of the latter 58
fragments 1 fragment was found to be most similar to a strain from
Laos (0%, 0 years to a MRCA), and 56 fragments were equidistant
to strains within and outside Laos (0–7.6%, 0–905 years to a
MRCA). 1 fragment was most similar to strains outside of Laos
(3.2%, 381 years to a MRCA).
In addition, recombination events were detected in the
previously published strains FJ023979 and FJ023832 and the
individual fragments (n=5) of these two recombinant strains were
attributed to genotype B and C. For 1 of these fragments the most
closely related strain was found within Laos (1%, 119 years to a
MRCA), while 3 fragments were equidistant to strains within and
outside Laos (0–7.6%, 0–905 years to a MRCA) and 1 fragment
was most closely related to strains outside of Laos (0%, 0 years to a
MRCA).
Amino acid sequence analysis of recombinant clones
Comparison of the 74 recombinant clones (including FJ023979,
FJ023832) with the consensus-50 alignment revealed several
consistent amino acid (AA) substitutions over the HBsAg. In these
clones AA substitutions occurred in 47 of 227 AA positions. In 10
of these positions substitution occurred in .5 clones: P11H (n=44
clones of d=3 donors and FJ023832), T/A45P (n=43, d=3 and
FJ023832), P/L49R (n=43, d=3 and FJ023832), C76F/S
(n=43, d=3 and FJ023832), T118A/M (n=17, d=5 and
FJ023832), F134I (n=42, d=3 and FJ023832), V190A (n=27,
d=2), I218L (n=41, d=3 and FJ023832), F219S (n=41, d=3
and FJ023832), C221F (n=41, d=3 and FJ023832). Further-
more, 3 recombinant clones revealed internal stop codons. Of the
observed amino acid substitutions only W182* had been described
as vaccine or treatment induced mutation [37,38,39].
Similarly to the clear genotypable strains, the 4 major HBsAg
subtypes [2] were found within the recombinant clones. For 16
clones as well as FJ023832 and FJ023832 the end or the beginning
of a recombinant fragment fell within the ‘a’-determinant. For
these clones the HBsAg subtypes were found to be ayw1 (n=14,
incl. FJ023832), adw1/2 (n=3) and adr (FJ023979). The
remaining clones were attributed to ayw1 (n=52) and adr (n=4).
Table 3. Number of PCR-induced recombinant clones in
control experiments.
Template concentration
Elongation time 1 ng 100 ng
20 s 6.41% (5/78 clones)* 39.39 (13/33 clones)
60 s 2.53% (2/79 clones) 0% (0/28 clones)
*Clones for each condition originate from HBV/B and HBV/C strains mixed for
amplification in ratios 1:25, 1:5, 1:1, 5:1 and 25:1.
doi:10.1371/journal.pone.0030245.t003
Figure 1. Phylogenetic clustering of selected HBV/B subgenotype B3, B5, B7 and B8 strains from GenBank and selected genotype B
strains from Laos. Non-subgenotypable clones are indicated by red diamonds. Scale bar indicates nucleotide substitutions per site.
doi:10.1371/journal.pone.0030245.g001
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yellow) involved in the recombination and regions homologous between at least 2 genotypes (grey). Recombinant strains from this study (red) or
detected in previously published strains (green) are indicated by diamonds.
doi:10.1371/journal.pone.0030245.g002
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Genotypes
The 42 HBsAg positive donors from which clones were derived,
were infected with a large variety of subgenotypes (B1, B2, B4, C1,
C5, I1, I2) (Table 2) similar to the one observed in our earlier
study [3]. Both genotypes B and C seemed to circulate with high
prevalences in the investigated cohort and were found in 85.7%
and 57.1% of investigated donors, with subgenotypes B4 (73.8% of
all donors) and C1 (57.1%) dominating. Subgenotyping of a
number of genotype B clones was, however, hampered by the mis-
assignment of subgenotypes B3, B5, B7 and B8 strains currently
available on GenBank (Figure 1). The low phylogenetic support
and genetic distances, sometimes below 3% (between B3 and B7)
[14], may require a later reclassification of genotype B strains.
The proposed genotype I, reported from several locations in
Laos and from Vietnam [3,4,5,6] shows evidence of recombina-
tions between genotypes C, G and perhaps A (by SimPlot
analyses), but is for the purpose of this study not considered a
recombination. While genotype I had been proposed on the basis
of at least 7.8% mean genetic distance to established genotypes
[3], its classification as a genotype remains an open but academic
debate [41] until more detailed guidelines for nomenclature and
the definition of recombinants are established.
As a result of the co-circulation of HBV subgenotypes in Laos,
5.8% (n=26) of the 446 analysable HBsAg positive blood donors,
were mixed infected with multiple HBV variants (Table 1). 17 of
these (3.8% of the 446 donors or 65.4% of the 26 mixed infected
donors) revealed at least one recombinant strain, all originating
from genotypes B and C (subgenotype C1).
The proposed genotype I, however, was relatively rare (3/42
donors). The most prominent Asian recombinants with B and C
parent sequences (subgenotypes B2-B4, formerly Ba) were found in
Laos in 31/42 donors, while the C/D recombinant predominant
in Tibet [27] was absent. These latter widespread recombinant
strains (B2-B4, I1, I2) seem to have long evolutionary histories in
Asia, originating from either single or multiple very similar
recombination events in a distant past, and are here no longer
considered recombinants. However, these subgenotypes of B
recombined further in Laos with HBV/C, most often C1, strains,
to form the relatively recent recombinants described in this study.
Recombinations
A surprisingly large number of 72 recombinants was found in
64.5% of mixed infected donors, representing 9.9% of all cloned
strains. These strains largely reflect recombinant strains circulating
in Laos and cannot be explained by PCR artefacts, as confirmed
by our control experiments.
127 of the genotypable 185 fragments belonged to the same
genotype as the co-infecting, non-recombinant strains. For 60 of
these, the most closely related known virus was found, although
not necessarily exclusively, in the same donor. Using a published
mutation rate of 4.2610
25 mutations per site and year [40], the
observed minimum genetic distances of 0–0.7% between parent
strain and recombinant fragment would correspond to 0–83 years
of evolution from a MRCA. For 13 of these fragments (all
originating from different cloned recombinants) even a lower or
the same time of evolution than the age of the donor was
calculated. Although, some donors with recombinant strains were
not co-infected with similar (non-recombinant) parent strains, the
above observations are suggestive of recent recombination events
and even within the individual donors. These putative recent
recombination events would explain the very limited spread of
each of the recombinants and that the recombinant virus strains
are largely distinct from each other (Figure 2). Only the proposed
genotype I and subgenotypes B2 and B4 represent older
recombinants in this region. The large number of apparently
independent recent recombination events is also reflected in an
unexpected diversity in recombination breakpoints (Figure 2), the
locations of which were highly variable throughout the S gene.
This variability in recombination sites was surprising, since earlier
studies [25,28,30,31] reported recombination breakpoints mostly
near gene boundaries. Interestingly, all recombined fragments,
independently of their breakpoints within the S gene, were
separated by homologous stretches of at least 17 nucleotides,
suggesting that this may be conducive to recombinations. The
breakpoint diversity in these recombinants also seems to be in
contrast to the dominant recombinants found in the rest of
mainland Asia [2,3,13,27].
When comparing the breakpoints of individual recombinant
clones more closely, clones with different recombination patterns
were not only found in different donors, but also within the same
donor (e.g. donor M05-1173) and in similar or different strains
from different donors (Figure 2). The relatively rare recombina-
tions with identical recombination patterns of the same genotypes
in different donors seem to further suggest their recent emergence,
probably within the last century. Thus, several of the above lines of
evidence, as well as our control experiments, suggest that many of
the recombinants described here have occurred in the same donor.
Surprisingly, amino acid substitutions were found in a large
proportion of investigated clones. However, these were largely free
of vaccine or treatment induced mutations. They furthermore
agreed largely with the HBsAg subtypes that had been described
previously in genotype B and C strains from Asia [2], indicating
that recombination between genotypes B and C is not adding to
the diversity of HBsAg subtypes in HBV strains circulating in
Laos.
Perinatal transmission is considered by some authors the most
common route of infection in Asia [42]. Furthermore, superinfec-
tions are considered to be rare and the ongoing immune response
and the replicative space may limit superinfections and acceler-
ation of chronic HBV even in regions of high endemicity [43].
Since furthermore quasispecies found within the individual donors
are unlikely to all be transmitted independently, one could argue
that all quasispecies would emerge from the initial pool of viruses
infecting at birth. Assuming further, that all quasispecies develop
from a single virus, we calculated the mutation rate, required for
the most distant quasispecies (of the same subgenotype) to develop
since birth of the donors. The median mutation rate was found to
be 1.58610
24 mutations per site and year, irrespective of whether
samples were included for which at least 5 or 10 clones were
available. This is well within the range of published short-term
mutation rates (range 1.4610
25 to 7.9610
24) [44]. These
estimates of short-term evolutionary rates of HBV are, however,
distinct from the much slower mutation rates (,10
29) recently
observed during co-evolution of HBV genomes in birds over
several millions of years [45]. The dramatic differences between
long and short-term mutation rates reflect the different evolution-
ary constraints during co-evolution with the host species and rapid
adaption under the pressure of the host immune system. In
addition, mutational saturation could be limiting and high
mutation rates would not be reflected in the long-term evolution
of a virus.
On the basis of the mutation rate 1.58610
24 mutations per site
and year, calculated above, the tMRCA would be reduced by a
factor of 3.8, largely corresponding to about 0–22 years of
evolution for those recombinant fragments for which the most
closely related known virus was found within the same donor,
Hepatitis B Virus in Laos
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lifetime of the donor. Even under the more likely assumption that
more than a single virus quasispecies was infectious at birth, the
above contention seems to suggest that the number of quasispecies
transmitted vertically is limited.
In conclusion, in Laos, multiple HBV sub-/genotypes co-
circulate, generating highly variable recent recombinants with
unique breakpoints, few of which seem to have spread within the
population. About 65% of mixed infected donors showed recent
recombinations in the S-gene alone, strongly suggesting that, at
least in Laos, mixed infections invariably lead to recombinations.
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